AcelRx Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for th…

Drug Manufacturers - Specialty & Generic
US, Hayward [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

AcelRx Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ACRX's Analysis
CIK: - CUSIP: 00444T100 LEI: - UEI: -
Secondary Listings
ACRX has no secondary listings inside our databases.